Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic Leukemia

Clinical trial NCT04094766 · WITHDRAWN

Trial details

NCT number

NCT04094766

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Status

WITHDRAWN

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-08-01

Primary completion

2020-08-30

Enrollment

0

View on ClinicalTrials.gov